CompaniesSyStemix

SyStemix

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

15

By Phase

PHASE1/PHASE2: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00003942
Hover over trial bars to see details

Recent Trials

NCT00003942Lead Sponsor
Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
PHASE1/PHASE2Unknown
15 participants
Started: Nov 30, 1998
Funding History (2)
DEF 14A
May 31, 1996
Filing
8-K
May 31, 1996
Filing
Related Companies
Novartis
acquired